SABBY MANAGEMENT, LLC - INNOVATE BIOPHARMACEUTICLS I ownership

Back to all holdings Add to watchlist

INNOVATE BIOPHARMACEUTICLS I's ticker is INNT and the CUSIP is 45782F105. A total of 22 filers reported holding INNOVATE BIOPHARMACEUTICLS I in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
SABBY MANAGEMENT, LLC ownership history of INNOVATE BIOPHARMACEUTICLS I
ValueSharesWeighting
Q4 2019$525,000
-60.7%
941,586
-24.6%
0.15%
-79.7%
Q3 2019$1,336,000
-13.8%
1,248,814
-6.5%
0.72%
-63.1%
Q2 2019$1,550,000–1,336,248–1.95%–
 Download
Other shareholders

There were no reported owners of INNOVATE BIOPHARMACEUTICLS I in Q4 2019.

NameSharesValueWeighting ↓
View complete list of INNOVATE BIOPHARMACEUTICLS I shareholders